Pro Dex Inc (PDEX) stock
PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/304% below fair value
$67.42−4.07 (-5.69%)
Close on Nov 12, 2026Market cap $215.74MP/E 18.6Yield –
Pro Dex operating margin
Operating margin is operating income as a percentage of revenue.
Pro Dex's operating margin for the twelve months ending Sep 30, 2026 was 16.8%. For fiscal 2026 it was 16.8%, against 16.1% the year before. The highest annual figure on record is 20.3% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 16.8% | +0.7 |
| FY2025 | Jun 30, 2025 | 16.1% | +2.7 |
| FY2024 | Jun 30, 2024 | 13.3% | +0.8 |
| FY2023 | Jun 30, 2023 | 12.5% | +0.3 |
| FY2022 | Jun 30, 2022 | 12.2% | +0.3 |
| FY2021 | Jun 30, 2021 | 11.9% | −8.4 |
| FY2020 | Jun 30, 2020 | 20.3% | +1.9 |
| FY2019 | Jun 30, 2019 | 18.4% | +7.7 |
| FY2018 | Jun 30, 2018 | 10.6% | −1.8 |
| FY2017 | Jun 30, 2017 | 12.5% | +8.3 |
| FY2016 | Jun 30, 2016 | 4.2% | +10.9 |
| FY2015 | Jun 30, 2015 | -6.7% | +0.8 |
| FY2014 | Jun 30, 2014 | -7.5% | +7.9 |
| FY2013 | Jun 30, 2013 | -15.5% | +4.9 |
| FY2012 | Jun 30, 2012 | -20.3% | −34.8 |
| FY2011 | Jun 30, 2011 | 14.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | 17.1% | +0.3 |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | 17.3% | +9.6 |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | 15.5% | −5.4 |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | 17.5% | +1.4 |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | 16.8% | −3.5 |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | 7.7% | −8.0 |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | 20.9% | +5.4 |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | 16.0% | +9.9 |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | 20.2% | +4.9 |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | 15.6% | +0.5 |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | 15.5% | −0.3 |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | 6.2% | −3.9 |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | 15.4% | +6.8 |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | 15.1% | +5.8 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | 15.8% | +4.8 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | 10.1% | −5.7 |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | 8.6% | −4.6 |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | 9.4% | +3.1 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | 11.0% | −4.9 |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | 15.7% | +9.4 |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | 13.2% | −4.8 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | 6.3% | −13.5 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | 15.9% | −4.1 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | 6.3% | −14.6 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | 18.0% | −2.6 |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | 19.8% | +2.9 |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | 20.0% | +6.9 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | 21.0% | +2.3 |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | 20.6% | −4.4 |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | 16.8% | +8.3 |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | 13.1% | +1.6 |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | 18.6% | +12.3 |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | 25.0% | +8.1 |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | 8.6% | −6.2 |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | 11.5% | −8.9 |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | 6.3% | +0.4 |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | 16.9% | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | 14.8% | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | 20.4% | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | 5.8% | – |
See a number that looks wrong?